GE prototype shrinks ultrasound

One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.

In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.

The addition of Caption AI to the handheld ultrasound device Vscan Air SL may facilitate optimal imaging for point-of-care cardiac evaluation.

Dr. Laurence Klotz discusses micro-ultrasound as a faster, less invasive, more cost-effective screening strategy compared to mpMRI in this podcast.

A nomogram that combines contrast-enhanced lymphatic ultrasound and grayscale ultrasound findings had an 88 percent AUC for prediction of three or more metastatic axillary lymph nodes in women with early breast cancer.

A multiparametric ultrasound model emphasizing attenuation coefficient assessment demonstrated a 77 percent AUC for detecting metabolic dysfunction-associated steatohepatitis (MASH), according to validation testing from a new multicenter study.